Product Description

Peripelvic reconstruction most commonly occurs in the setting of oncologic ablative surgery. The peripelvic area contains several distinct reconstructive regions, including vagina, vulva, penis, and scrotum. Each area provides unique reconstructive considerations. In addition, prior or future radiation therapy or chemotherapy along with cancer cachexia can increase the complexity of reconstruction.

Learning Objectives

After viewing this course, the participant should be able to:

1. Understand the anatomy of the peripelvic area. 
2. Understand the advantages and disadvantages of performing peripelvic reconstruction in patients undergoing oncologic resection. 
3. Select the appropriate local, pedicled, or free-flap reconstruction based on the location of the defect and donor-site characteristics. 

Faculty

Joseph Disa, MD

Plastic and Reconstruction Surgery® Editors:

Editor-in-Chief: Rod J. Rohrich, MD 

Co-Editor: James M. Stuzin, MD 

Section Editor: Donald H. Lalonde, MD

Accreditation Information

Patient Safety Credit: 0.5 

Media: Journal CME Article, Video

Published Date: 10/1/2017

Expiration Date: 10/1/2020

Estimated time to complete this course: 1.0 hour 

Directly provided by the American Society of Plastic Surgeons^® (ASPS^®)

Accreditation Statement

The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience

This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Disclosures

Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

Product Code: 22318